Clotting Factor Concentrate Better Than Frozen Plasma for Preventing Bleeding After Heart Surgery, According to Clinical Trial Results Clotting Factor Concentrate Better Than Frozen Plasma for Preventing Bleeding After Heart Surgery, According to Clinical Trial Results

Clotting Factor Concentrate Better Than Frozen Plasma for Preventing Bleeding After Heart Surgery, According to Clinical Trial Results

Clinical trial results published today in the Journal of the American Medical Association indicate a potential shift in managing bleeding complications after major open-heart surgery.
Milk as Medicine: New Study Shows Breast Milk Transforms Challenges into Triumphs Milk as Medicine: New Study Shows Breast Milk Transforms Challenges into Triumphs

Milk as Medicine: New Study Shows Breast Milk Transforms Challenges into Triumphs

In 2010, University of Oklahoma researcher David Fields, Ph.D., was pouring over research data when he discovered something he thought was odd: His data showed that at 6 months of age, formula-fed babies born of...
OU Researcher Leverages Technology for Alcohol Disorder Interventions in Primary Care OU Researcher Leverages Technology for Alcohol Disorder Interventions in Primary Care

OU Researcher Leverages Technology for Alcohol Disorder Interventions in Primary Care

According to the Centers for Disease Control and Prevention, 1 in 7 adults in the United States will experience a substance use disorder during their lifetime. University of Oklahoma College of Medicine faculty...
Mannel Re-Elected Group Chair of NRG Oncology Mannel Re-Elected Group Chair of NRG Oncology

Mannel Re-Elected Group Chair of NRG Oncology

Robert Mannel, M.D., director of OU Health Stephenson Cancer Center and a professor of obstetrics and gynecology at the University of Oklahoma College of Medicine, has been re-elected as one of three group chairs of...
Delay of More Than 42 Days for Breast Cancer Surgery Raises Death Risk for Certain Subtypes, OU Study Finds Delay of More Than 42 Days for Breast Cancer Surgery Raises Death Risk for Certain Subtypes, OU Study Finds

Delay of More Than 42 Days for Breast Cancer Surgery Raises Death Risk for Certain Subtypes, OU Study Finds

Patients with certain subtypes of breast cancer may face a higher risk of death from the cancer if they wait more than 42 days after diagnosis to have surgery, according to newly published research from the...
124678910Last